Search research articles
Contact Us
Filters
Showing results (51-60 of 201) with videos related to
Page
of 21
Sort By:
The Journal of Molecular Diagnostics : JMD
|
May 20, 2017
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia
Daniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
Leukemia & Lymphoma
|
October 25, 2022
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome
David C Helfgott, Sabrina Racine-Brzostek, Kelsey J Short, et al.
Leukemia & Lymphoma
|
June 27, 2009
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial
Azra Raza, Joseph G Jurcic, Gail J Roboz, et al.
Leukemia & Lymphoma
|
February 15, 2021
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome
Gail J Roboz, Pinkal Desai, Sangmin Lee, et al.
Cancer
|
October 6, 2018
Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions
David P Steensma, Andrew M Brunner, Amy E DeZern, et al.
Leukemia Research
|
June 15, 2007
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia
Francis J Giles, Alan F List, Michael Carroll, et al.
Nature Biotechnology
|
January 8, 2020
The therapeutic landscape for cells engineered with chimeric antigen receptors
Matthew MacKay, Ebrahim Afshinnekoo, Jonathan Rub, et al.
British Journal of Haematology
|
December 12, 2025
Oral azacitidine maintenance therapy for patients with acute myeloid leukaemia and myelodysplasia-related changes: Post hoc analysis of the QUAZAR AML-001 trial
Maria Teresa Voso, Stéphane de Botton, Michael Pfeilstöcker, et al.
Cancer Medicine
|
December 22, 2020
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium
Rami S Komrokji, Najla H Al Ali, David Sallman, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 201) with videos related to
Sort By:
Page
of 21
The Journal of Molecular Diagnostics : JMD
|
May 20, 2017
Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia
Daniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
Leukemia & Lymphoma
|
October 25, 2022
Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome
David C Helfgott, Sabrina Racine-Brzostek, Kelsey J Short, et al.
Leukemia & Lymphoma
|
June 27, 2009
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial
Azra Raza, Joseph G Jurcic, Gail J Roboz, et al.
Leukemia & Lymphoma
|
February 15, 2021
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome
Gail J Roboz, Pinkal Desai, Sangmin Lee, et al.
Cancer
|
October 6, 2018
Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions
David P Steensma, Andrew M Brunner, Amy E DeZern, et al.
Leukemia Research
|
June 15, 2007
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia
Francis J Giles, Alan F List, Michael Carroll, et al.
Nature Biotechnology
|
January 8, 2020
The therapeutic landscape for cells engineered with chimeric antigen receptors
Matthew MacKay, Ebrahim Afshinnekoo, Jonathan Rub, et al.
British Journal of Haematology
|
December 12, 2025
Oral azacitidine maintenance therapy for patients with acute myeloid leukaemia and myelodysplasia-related changes: Post hoc analysis of the QUAZAR AML-001 trial
Maria Teresa Voso, Stéphane de Botton, Michael Pfeilstöcker, et al.
Cancer Medicine
|
December 22, 2020
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium
Rami S Komrokji, Najla H Al Ali, David Sallman, et al.
Page
of 21